Sector valuations Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 05/06/2026 BST 5-day change 1st Jan Change
0.2125 USD +7.27% Intraday chart for Virax Biolabs Group Limited +12.37% -38.55%
Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-0.53x - 0.01x - - - - 4.23M
29.32x3.75x1.3x5.21x16.14x22.65x1.12% 42.68B
-18.74x13.7x-0.55x284.14x-16.99x-16.72x-.--% 31.73B
22.28x4.23x4.43x2.56x11.07x16.87x-.--% 30.62B
40.18x5.87x0.24x4.01x25.73x30.51x-.--% 30.03B
28.96x2.16x0.87x7.47x19.23x23.02x0.42% 24.25B
22.57x2.36x0.78x1.96x8.6x13.62x1.18% 13.17B
26.66x13.35x2.32x4.26x19.41x20.35x-.--% 12.97B
-20.79x307.6x-0.41x13.58x-20.21x-19.65x-.--% 12.31B
23.79x1.17x0.2x1.71x10.36x11.87x-.--% 11.44B
-23.06x20.57x-0.54x5.64x138.25x-435.07x-.--% 8.34B
29.56x2.65x-0.1x2.74x10.69x12.97x-.--% 8.73B
44.59x3.77x0.29x6.67x18.94x20.82x0.62% 8.14B
-22.84x39.7x1.12x1736.22x-24.76x-25.37x-.--% 8.08B
17.5x1.97x2.17x3.76x10.27x12.84x-.--% 7.59B
-16.68x6.32x-1.29x1453.01x-13.71x-13.03x-.--% 7.08B
-107.81x3.87x0.84x4.47x23.7x142.19x-.--% 7.13B
-20.33x6.03x-15.77x389.16x-16.21x-16.2x-.--% 6.51B
Average 3.03x 25.83x -0.23x 230.97x 12.97x -11.67x 0.2% 15.04B
Weighted average by Cap. 12.05x 20.79x 0.58x 136.37x 11.84x 0.48x 0.29%
Other Biotechnology & Medical Research